Liquichek Hematology-16 Control

Products	Liquichek Hematology-16 Control
Company	Bio-Rad Laboratories
Item	Liquichek Hematology-16 Control
Features	6 month shelf life at 28C 14 day open-vial stability at 28C Assayed for most 216 parameter instruments WBC differentials with normal and abnormal distributions Stabilized human RBCs Low, normal and high platelet counts Simultaneous expiration of all levels
Description	Liquichek Hematology-16 Control is specifically designed for use on most hematology analyzers that measure up to 16 parameters and 3-part white blood cell differentials. This trilevel control can be used on either manual sampling or automatic cap-piercing instruments.
Info	Bio-Rad Laboratories Customer Service: 1-800-2-BIORAD Web site: http://www.bio-rad.com

TAG: Liquichek Hematology Control

Short examining bridge for insertion of instruments

Designed for accurate articulation of flexible devices.

...PVC, Length 30cm (12") Spiral Tip, 1/56" female th...struments are constructed of a strong but flexible... which allow interchangeability with other brands....hey are also economically priced to give you signi...

It is available in a 5cc-balloon version with round tip and two opposing eyes, and a 30cc-balloon version with two staggered eyes. BARDEX Silicone-Elastomer Foley Catheters are also available in kits

Medicine Products:

S-Series Cystourethroscope Short Bridge, examining P-Series Cystourethroscope Albarran Bridge, single-horn Filiform Spiral Tip BARDEX Silicone-Elastomer 2-Way Foley Catheters

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...annual celebration climaxed Sunday with a vibrant ...ronto's streets Sunday afternoon to enjoy the cit...ration. The parade is Pride Week's signature event...laborate costumes and floats.It was the culminatio...

...d who tested positive for bird flu has recovered f...atment, a doctor said Saturday. The girl, admitte...a island with bird flu symptoms, had contact with ...o tested positive with the disease. "Lab results f...

...ts have been coming to Spain's sun-kissed eastern ...ts among them are connoisseurs of the climate's re... progresses, more and more health "tourists" and f...a of retirement by the sea have been making increa...

...in Chhattisgarh was one of the first to receive re... to ensure sanitation facilities in rural areas . ...t to use them. Each of the 33 families of Dabena i...th latrines constructed near their houses under th...

Other Medicine News:Health News:Biggest Gay Pride Celebration in Toronto 2 Health News:Health Tourists Put Spanish Service Under Strain 2 Health News:'Walk of Shame' Triggers Toilet Consciousness 2 Health News:'Walk of Shame' Triggers Toilet Consciousness 3

Biggest Gay Pride Celebration in Toronto Indonesia Bird Flu Victim in Recovery Health Tourists Put Spanish Service Under Strain 'Walk of Shame' Triggers Toilet Consciousness

(Date:8/19/2008)...., Aug. 19 /- Addrenex Pharmaceutical...ategic hires this month to,further its goal of ide...s,as possible over the next 18 months., The fast-...rrors the,company,s recent successes in developing...hyperactivity disorder and CloniBID for hypertensi...

(Date:8/19/2008)...Conn., Aug. 19 /- VION,PHAR...day that it had,entered into an agreement with the...ogy Oncology (the "HOVON") to conduct a clinical t...ith standard remission-induction,therapy in patien...ogenous,leukemia (AML) and high-risk myelodysplasi...

(Date:8/18/2008).... 18 /PRNewswire-USNewswire/ -- Boston University ...the Center for Human Genetics, Inc.,("CHG") and Di...University,announced that CHG will no longer offe...Athena Diagnostics, Inc., These patented tests in...ated to A1555G or Connexin 26 mutations, developme...

(Date:8/18/2008)...der with Strong Clinical Research Relationships an...ations to Lead Commercialization, SANTA CLARA, Ca... Inc.,(OTC Bulletin Board: NWCI) a cardiac diagno...ncent W. Renz has joined NewCardio as its presiden...zation effort, to include,business development, cl...

Breaking Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2 Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3 Vincent W. Renz Joins NewCardio as President 2 Vincent W. Renz Joins NewCardio as President 3 Vincent W. Renz Joins NewCardio as President 4 Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston MA 36 1 Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston MA 36 2 Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston MA 36 3 Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 33 1 Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 33 2 Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 33 3 Dynavax Issued Landmark Patent Covering Second Generation TLR9 Agonists 30 1 Dynavax Issued Landmark Patent Covering Second Generation TLR9 Agonists 30 2 China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 27 1 China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 27 2 China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 27 3

[0] Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation [0] Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy [0] Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services [0] Vincent W. Renz Joins NewCardio as President

...resented at ECCMID/ICC, MUNICH, Germany, April 03,...announced results from two studies showing the,imp...wth in vitro,when tested with a common wetting age...e activity of oritavancin against S.,pneumoniae in...lipoglycopeptide antibiotic, is Targanta,s lead pr...

... Suppresses Amyloid Plaque,Formation , ANNAPOLIS, ...biodefense company specializing in the development...against chemical and,biological terrorism, announc...lcholinesterase (rBChE) research program were,rece... on,Alzheimer,s and Parkinson,s Diseases in Salzbu...

Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6

Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research